We are delighted to invite you to take part in the scientific and practical conference with international participation Professor Zaritskey Discussion Club to be held on September 2–3, 2022. The conference will take place in hybrid format.
The event will be held as part of the programme of the WCRC for Personalized Medicine.
The conference will focus on the problems of diagnosis and therapy of patients with acute myeloid leukemia, chronic lymphoproliferative and myeloproliferative disorders. Challenges in the diagnosis and treatment of patients with hematological malignancies will be discussed.
Hematologists, morphologists and specialists in molecular genetic testing are invited to attend.
Main topics to be covered include:
- Acute myeloid leukemia – risk-adapted therapy, including allo-HSCT
- Chronic lymphoproliferative disorders — the role of new therapies in patient management
- Chronic myeloproliferative disorders— optimization of targeted therapy, the role of allo-HSCT
The event will be held in Russian and English with simultaneous interpretation.
In the context of the COVID-19 pandemic, the conference will be organized in compliance with all necessary epidemiological measures and regulations in force at the time of the event.
If large events are banned, the conference will be moved to a fully online format as scheduled.
For participation details, please contact:
Ekaterina Pevneva, Head of Cooperation and Marketing Department
Tel: +7 (812) 702-37-49 (ext. 005110)